Analyzing a Biomarker As A Proof Of Concept
Biomarker Analysis with the Mixed Modelling Methodology Two doses of a therapeutic vaccine were tested simultaneously in a randomized phase II…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.
Renseigner une description via Articles > Categories > Case Studies > Champ 'Description' pour remplacer ce Lorem ipsum.
Biomarker Analysis with the Mixed Modelling Methodology Two doses of a therapeutic vaccine were tested simultaneously in a randomized phase II…
Meta-Analysis performed with IDDI’s Methodology Skills IDDI has been involved in numerous meta-analyses to directly or indirectly support new drug applications….
Surrogate endpoint for overall survival We managed to prove, using data from a randomized trial comparing Ceplene + IL-2 to…
A multi-center phase II trial was conducted in just over 100 patients to compare metabolic changes in the prostate after…